Cargando…
Assessment of cognitive dysfunction using the Montreal Cognitive Assessment test: rate, severity and comparison with the Clock test alone in a population of patients referred for TAVI
BACKGROUND: Although not recommended in routine practice, the detection and quantification of Cognitive Dysfunction (CD) in older patients might have an impact on clinical decisions. We assessed the rate and severity of CD in an unselected population of patients referred for Transcatheter Aortic Val...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707928/ http://dx.doi.org/10.1093/ehjdh/ztab104.3080 |
_version_ | 1784840809595535360 |
---|---|
author | Monnin, C Besutti, M Ecarnot, F Guillon, B Chatot, M Chopard, R Yahia, M Meneveau, N Schiele, F |
author_facet | Monnin, C Besutti, M Ecarnot, F Guillon, B Chatot, M Chopard, R Yahia, M Meneveau, N Schiele, F |
author_sort | Monnin, C |
collection | PubMed |
description | BACKGROUND: Although not recommended in routine practice, the detection and quantification of Cognitive Dysfunction (CD) in older patients might have an impact on clinical decisions. We assessed the rate and severity of CD in an unselected population of patients referred for Transcatheter Aortic Valve Implantation (TAVI) using the Montreal Cognitive Assessment (MoCA) and using the Clock Drawing Test (ClockT) alone. METHODS: The MoCA was performed before TAVI by an experienced operator. The ClockT was scored out of 10 points according to the Rouleau rating scale. CD was defined according to the MoCA score: No CD if score ≥26, mild CD if score 18–25, moderate if 10–17 and severe if <10. Inter-observer reliability of scoring on the ClockT was estimated with the Bland-Altman method. Agreement between MoCA scores and the ClockT for ruling out and for detecting CD were measured with the Kappa coefficient. RESULTS: MoCA was performed in 83 consecutive patients referred for TAVI, median age 85 years. The mean time required for assessment was 11±2 min for the MoCA and 3±2 min for the ClockT. The mean MoCA score was 21±4.5: CD was excluded in 17 (20%) pts, mild CD was found in 50 (60%), moderate in 15 (18%) and severe in one (1%). The median ClockT score was 8 (interquartile 6; 9), with excellent inter-observer concordance (Kappa= 0.84). Overall, 51% of the variance of the MoCA score was explained by the ClockT alone according to multiple regression. A ClockT <7 detected a group with significantly lower MoCA score, compared to pts with higher ClockT scores (figure). CONCLUSION: Among patients referred for TAVI, CD can be excluded using the MoCA test in 20%, while moderate or severe CD is observed in 18%. The ClockT alone is faster to implement, reliable to interpret and enabled detection of patients with moderate CD when Rouleau scoring was <7. FUNDING ACKNOWLEDGEMENT: Type of funding sources: None. |
format | Online Article Text |
id | pubmed-9707928 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-97079282023-01-27 Assessment of cognitive dysfunction using the Montreal Cognitive Assessment test: rate, severity and comparison with the Clock test alone in a population of patients referred for TAVI Monnin, C Besutti, M Ecarnot, F Guillon, B Chatot, M Chopard, R Yahia, M Meneveau, N Schiele, F Eur Heart J Digit Health Abstracts BACKGROUND: Although not recommended in routine practice, the detection and quantification of Cognitive Dysfunction (CD) in older patients might have an impact on clinical decisions. We assessed the rate and severity of CD in an unselected population of patients referred for Transcatheter Aortic Valve Implantation (TAVI) using the Montreal Cognitive Assessment (MoCA) and using the Clock Drawing Test (ClockT) alone. METHODS: The MoCA was performed before TAVI by an experienced operator. The ClockT was scored out of 10 points according to the Rouleau rating scale. CD was defined according to the MoCA score: No CD if score ≥26, mild CD if score 18–25, moderate if 10–17 and severe if <10. Inter-observer reliability of scoring on the ClockT was estimated with the Bland-Altman method. Agreement between MoCA scores and the ClockT for ruling out and for detecting CD were measured with the Kappa coefficient. RESULTS: MoCA was performed in 83 consecutive patients referred for TAVI, median age 85 years. The mean time required for assessment was 11±2 min for the MoCA and 3±2 min for the ClockT. The mean MoCA score was 21±4.5: CD was excluded in 17 (20%) pts, mild CD was found in 50 (60%), moderate in 15 (18%) and severe in one (1%). The median ClockT score was 8 (interquartile 6; 9), with excellent inter-observer concordance (Kappa= 0.84). Overall, 51% of the variance of the MoCA score was explained by the ClockT alone according to multiple regression. A ClockT <7 detected a group with significantly lower MoCA score, compared to pts with higher ClockT scores (figure). CONCLUSION: Among patients referred for TAVI, CD can be excluded using the MoCA test in 20%, while moderate or severe CD is observed in 18%. The ClockT alone is faster to implement, reliable to interpret and enabled detection of patients with moderate CD when Rouleau scoring was <7. FUNDING ACKNOWLEDGEMENT: Type of funding sources: None. Oxford University Press 2021-12-29 /pmc/articles/PMC9707928/ http://dx.doi.org/10.1093/ehjdh/ztab104.3080 Text en Reproduced from: European Heart Journal, Volume 42, Issue Supplement_1, October 2021, ehab724.3080, https://doi.org/10.1093/eurheartj/ehab724.3080 by permission of Oxford University Press on behalf of the European Society of Cardiology. The opinions expressed in the Journal item reproduced as this reprint are those of the authors and contributors, and do not necessarily reflect those of the European Society of Cardiology, the editors, the editorial board, Oxford University Press or the organization to which the authors are affiliated. The mention of trade names, commercial products or organizations, and the inclusion of advertisements in this reprint do not imply endorsement by the Journal, the editors, the editorial board, Oxford University Press or the organization to which the authors are affiliated. The editors and publishers have taken all reasonable precautions to verify drug names and doses, the results of experimental work and clinical findings published in the Journal. The ultimate responsibility for the use and dosage of drugs mentioned in this reprint and in interpretation of published material lies with the medical practitioner, and the editors and publisher cannot accept liability for damages arising from any error or omissions in the Journal or in this reprint. Please inform the editors of any errors. © The Author(s) 2021. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Monnin, C Besutti, M Ecarnot, F Guillon, B Chatot, M Chopard, R Yahia, M Meneveau, N Schiele, F Assessment of cognitive dysfunction using the Montreal Cognitive Assessment test: rate, severity and comparison with the Clock test alone in a population of patients referred for TAVI |
title | Assessment of cognitive dysfunction using the Montreal Cognitive Assessment test: rate, severity and comparison with the Clock test alone in a population of patients referred for TAVI |
title_full | Assessment of cognitive dysfunction using the Montreal Cognitive Assessment test: rate, severity and comparison with the Clock test alone in a population of patients referred for TAVI |
title_fullStr | Assessment of cognitive dysfunction using the Montreal Cognitive Assessment test: rate, severity and comparison with the Clock test alone in a population of patients referred for TAVI |
title_full_unstemmed | Assessment of cognitive dysfunction using the Montreal Cognitive Assessment test: rate, severity and comparison with the Clock test alone in a population of patients referred for TAVI |
title_short | Assessment of cognitive dysfunction using the Montreal Cognitive Assessment test: rate, severity and comparison with the Clock test alone in a population of patients referred for TAVI |
title_sort | assessment of cognitive dysfunction using the montreal cognitive assessment test: rate, severity and comparison with the clock test alone in a population of patients referred for tavi |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707928/ http://dx.doi.org/10.1093/ehjdh/ztab104.3080 |
work_keys_str_mv | AT monninc assessmentofcognitivedysfunctionusingthemontrealcognitiveassessmenttestrateseverityandcomparisonwiththeclocktestaloneinapopulationofpatientsreferredfortavi AT besuttim assessmentofcognitivedysfunctionusingthemontrealcognitiveassessmenttestrateseverityandcomparisonwiththeclocktestaloneinapopulationofpatientsreferredfortavi AT ecarnotf assessmentofcognitivedysfunctionusingthemontrealcognitiveassessmenttestrateseverityandcomparisonwiththeclocktestaloneinapopulationofpatientsreferredfortavi AT guillonb assessmentofcognitivedysfunctionusingthemontrealcognitiveassessmenttestrateseverityandcomparisonwiththeclocktestaloneinapopulationofpatientsreferredfortavi AT chatotm assessmentofcognitivedysfunctionusingthemontrealcognitiveassessmenttestrateseverityandcomparisonwiththeclocktestaloneinapopulationofpatientsreferredfortavi AT chopardr assessmentofcognitivedysfunctionusingthemontrealcognitiveassessmenttestrateseverityandcomparisonwiththeclocktestaloneinapopulationofpatientsreferredfortavi AT yahiam assessmentofcognitivedysfunctionusingthemontrealcognitiveassessmenttestrateseverityandcomparisonwiththeclocktestaloneinapopulationofpatientsreferredfortavi AT meneveaun assessmentofcognitivedysfunctionusingthemontrealcognitiveassessmenttestrateseverityandcomparisonwiththeclocktestaloneinapopulationofpatientsreferredfortavi AT schielef assessmentofcognitivedysfunctionusingthemontrealcognitiveassessmenttestrateseverityandcomparisonwiththeclocktestaloneinapopulationofpatientsreferredfortavi |